Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Rottenberg

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Nature Communications|July 18, 2017
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cellsPepijn M Schoonen, Francien Talens, Colin Stok, et al.
Communications Biology|October 6, 2025
NAA60 facilitates LRRC8A- and LRRC8D-mediated platinum drug uptakeCarmen Alexandra Widmer, Anna Moyseos, Ismar Klebic, et al.
Nature Communications|July 21, 2024
Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasitesMarina Maurizio, Maria Masid, Kerry Woods, et al.
Animals : an Open Access Journal From MDPI|August 12, 2023
Artificial Intelligence to Predict the BRAF V595E Mutation in Canine Urinary Bladder Urothelial CarcinomasLeonore Küchler, Caroline Posthaus, Kathrin Jäger, et al.
Nature Communications|December 19, 2018
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivityJordan R Becker, Raquel Cuella-Martin, Marco Barazas, et al.
Cancer Research|February 11, 2010
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecanSerge A L Zander, Ariena Kersbergen, Eline van der Burg, et al.
Cancer Research|December 12, 2018
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient TumorsMarco Barazas, Alessia Gasparini, Yike Huang, et al.
Nature Methods|December 20, 2017
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistanceAlexandra A Duarte, Ewa Gogola, Norman Sachs, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Nature Communications|July 18, 2017
Progression through mitosis promotes PARP inhibitor-induced cytotoxicity in homologous recombination-deficient cancer cellsPepijn M Schoonen, Francien Talens, Colin Stok, et al.
Communications Biology|October 6, 2025
NAA60 facilitates LRRC8A- and LRRC8D-mediated platinum drug uptakeCarmen Alexandra Widmer, Anna Moyseos, Ismar Klebic, et al.
Nature Communications|July 21, 2024
Host cell CRISPR genomics and modelling reveal shared metabolic vulnerabilities in the intracellular development of Plasmodium falciparum and related hemoparasitesMarina Maurizio, Maria Masid, Kerry Woods, et al.
Animals : an Open Access Journal From MDPI|August 12, 2023
Artificial Intelligence to Predict the BRAF V595E Mutation in Canine Urinary Bladder Urothelial CarcinomasLeonore Küchler, Caroline Posthaus, Kathrin Jäger, et al.
Nature Communications|December 19, 2018
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivityJordan R Becker, Raquel Cuella-Martin, Marco Barazas, et al.
Cancer Research|February 11, 2010
Sensitivity and acquired resistance of BRCA1;p53-deficient mouse mammary tumors to the topoisomerase I inhibitor topotecanSerge A L Zander, Ariena Kersbergen, Eline van der Burg, et al.
Cancer Research|December 12, 2018
Radiosensitivity Is an Acquired Vulnerability of PARPi-Resistant BRCA1-Deficient TumorsMarco Barazas, Alessia Gasparini, Yike Huang, et al.
Nature Methods|December 20, 2017
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistanceAlexandra A Duarte, Ewa Gogola, Norman Sachs, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cancer Cell|December 17, 2011
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistanceRinske Drost, Peter Bouwman, Sven Rottenberg, et al.
Pageof 13